↓ Skip to main content

Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study

Overview of attention for article published in Inflammatory Bowel Diseases, August 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
1 X user

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study
Published in
Inflammatory Bowel Diseases, August 2023
DOI 10.1093/ibd/izad135
Pubmed ID
Authors

Tamás Resál, Péter Bacsur, Csilla Keresztes, Anita Bálint, Renáta Bor, Anna Fábián, Bernadett Farkas, Kostas Katsanos, George Michalopoylos, Davide Giuseppe Ribaldone, Mohamed Attauabi, Mirabella Zhao, Hadar Amir Barak, Henit Yanai, Cristina Bezzio, Antonio Rispo, Fabiana Castiglione, Ariella Bar-Gil Shitrit, Daniela Pugliese, Alessandro Armuzzi, Edoardo Vincenzo Savarino, Martin Kolar, Milan Lukáš, Elena Chashkova, Rafał Filip, Aurore Rozieres, Stéphane Nancey, Željko Krznarić, Eszter Schäfer, Tamás Szamosi, Patrícia Sarlós, Matej Franko, David Drobne, Oleg V Knyazev, Anna V Kagramanova, Jimmy Limdi, Panu Wetwittayakhlang, Peter L Lakatos, Nitsan Maharshak, Lian Bannon, Tibor Nyári, Zoltán Szepes, Klaudia Farkas, Simone Saibeni, Kristyna Kastylova, Jakob Benedict Seidelin, Johan Burisch, Helga Hajdú, Tamás Molnár

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 25%
Unknown 3 75%
Readers by discipline Count As %
Linguistics 1 25%
Medicine and Dentistry 1 25%
Unknown 2 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 August 2023.
All research outputs
#1,598,312
of 24,297,440 outputs
Outputs from Inflammatory Bowel Diseases
#202
of 3,631 outputs
Outputs of similar age
#16,199
of 215,822 outputs
Outputs of similar age from Inflammatory Bowel Diseases
#3
of 27 outputs
Altmetric has tracked 24,297,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,631 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,822 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.